Winner, Joel G <br/><br/>
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.  [electronic resource] 

 -  Discovery medicine  Nov 2013 
 - 219-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1944-7930 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antidepressive Agents--therapeutic use<br/>Depressive Disorder, Major--drug therapy<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Genotype<br/>Humans<br/>Treatment Outcome